Description

GE 2270A (MDL 62879) is an antibiotic. GE 2270A inhibits gram-positive bacteria and anaerobes by inhibiting protein synthesis. GE 2270A can be used for the research of infection[1][2].—COVID-19-immunoregulation–C56H55N15O10S6—-[1]Landini P, B et al. Inhibition of bacterial protein synthesis by elongation-factor-Tu-binding antibiotics MDL 62,879 and efrotomycin. Biochem J. 1992 May 1;283 ( Pt 3)(Pt 3):649-52.|[2]Anborgh PH, Parmeggiani A. New antibiotic that acts specifically on the GTP-bound form of elongation factor Tu. EMBO J. 1991 Apr;10(4):779-84.–134861-34-0–1290.52—-O=C1C2=CSC(C3=CC=C(C4=NC(C5=N[C@@H](CO5)C(N6[C@@H](CCC6)C(N)=O)=O)=CS4)N=C3C7=CSC(C8=CSC([C@](NC(CNC(C9=C(SC([C@@H](NC(C=C(C)SC([C@@H](N1)CC(NC)=O)=N)=O)C(C)C)=N9)COC)=O)=O)([H])[C@H](C=CC=CC=C)O)=N8)=N7)=N2–Infection–10 mM in DMSO–Antibiotic;Bacterial—-Anti-infection–Peptides